安藤達也

アンドウタツヤ | Ando Tatsuya

所属機関・部署：
職名：助教

研究分野 (3件)：消化器内科学 , 腫瘍生物学 , 免疫学

研究キーワード (1件)：肝再生、肝疾患、腫瘍免疫、炎症

競争的資金等の研究課題 (3件)：

論文 (29件)：

Kouhei Sakurai, Tatsuya Ando, Yasuhiro Sakai, Yuichiro Mori, Satoru Nakamura, Taku Kato, Hiroyasu Ito. PROX1 is a regulator of neuroendocrine-related gene expression in lung carcinoid. Human Cell. 2024. 37. 5. 1559-1566
Masaki Ishikawa, Yasuko Yamamoto, Bolati Wulaer, Kazuo Kunisawa, Hidetsugu Fujigaki, Tatsuya Ando, Hiroki Kimura, Itaru Kushima, Yuko Arioka, Youta Torii, et al. Indoleamine 2,3-dioxygenase 2 deficiency associates with autism-like behavior via dopaminergic neuronal dysfunction. The FEBS journal. 2024. 291. 5. 945-964
TAKU KATO, KYOJIRO KAWAKAMI, KOSUKE MIZUTANI, TATSUYA ANDO, YASUHIRO SAKAI, KOUHEI SAKURAI, SHOHEI TOYOTA, HIDETOSHI EHARA, HIROYASU ITO, MASAFUMI ITO. H19in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients. Cancer Genomics - Proteomics. 2023. 20. 5. 456-468
Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, Honomi Ando, Yasuko Yamamoto, Kuniaki Saito. Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced Nephrotoxicity. Molecular cancer therapeutics. 2023. OF1-OF9
Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, Honomi Ando, Yasuko Yamamoto, Kuniaki Saito. Identification of 2',4',6'-trihydroxyacetophenone as promising cysteine conjugate beta-lyase inhibitor for preventing cisplatin-induced nephrotoxicity. Molecular cancer therapeutics. 2023

経歴 (6件)：

全件表示

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

安藤 達也